- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04743973
A Study to Asses Wellness Using a Brain Sensing Device on Physicians
December 4, 2024 updated by: Ivana T Croghan, PhD, Mayo Clinic
A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device (Muse-S) in Practicing Physicians
A study to asses the feasibility of physicians using a wearable brain sensing wellness device during a time of increased work load, patient volume and stressors to assess the association between duration of active state and calm state as measured by the wearable brain sensing wellness device, and quality of life (QOL), subjective stress, sleep and resilience.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants will be instructed on how to use a brain sensing device and corresponding digital application to engage in structured digital mindfulness practices daily for 3 months.
Subjects will be requested to use the device and practice daily, but the amount of time and frequency daily will be to their choosing.
Subjects will also complete questionnaires and cognitive based testing throughout participation.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years of age or older at time of consent
- Practicing Physicians at Mayo Clinic
- Not pregnant by subject self-report at time of consent
- Have the ability to provide informed consent
- Have the ability to complete all aspects of this trial
- Have access to a smart phone or tablet device
- Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-S™ system, as determined by the clinical investigators
Exclusion Criteria:
- Used an investigational drug within the past 30 days
- Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis
- Currently (within 3 weeks) been enrolled in another clinical or research program (e.g. CAM) which intervenes on the patients' QOL, or stress
- An unstable medical or mental health condition as determined by the physician investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Practicing Physicians
Practicing physicians at Mayo Clinic caring for patients during the COVID 19 pandemic will receive the Muse S™ Headband system, and will be asked to utilize it at least 4 times per week for a minimum of 10 minutes each time over a period of 3 months (12 weeks).
|
Brain sensing headband that measures brain activity by detecting electrical impulses created by the brain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency Adherence to Intervention
Time Frame: 3 months
|
Summarizing frequency subjects use intervention during active study participation (during 3 month study period)
|
3 months
|
|
Duration Adherence to Intervention
Time Frame: 3 months
|
Summarizing duration of time subjects use intervention during active study participation (during 3 month time period)
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale (PSS) Score Difference
Time Frame: 90 days
|
The Perceived Stress Scale (PSS) is a 10-item 5-point Likert scale that measures global life stress by assessing the degree (Never, almost never, sometimes, often and very often) to which experiences are appraised as uncontrollable or unpredictable.
Scores can range from 0 to 40, with higher scores indicating greater perceived stress.
The score difference is the average change from Day 90 to Baseline.
|
90 days
|
|
Resilience Score Difference
Time Frame: 90 days
|
Resilience was measured using the Connor-Davison Resilience Scale 10 (CD-RS10).
This is a 10-item, 5-point likert scale, validated, scoring system.
Scores can range from 0 to 40, with higher scores indicating higher resilience.
The CD-RS10 is a reliable means of assessing resilience and most often used in medical and/or disaster studies.
Difference from Day 90 to baseline for the resilience score
|
90 days
|
|
LASA Score Difference
Time Frame: 90 days
|
Quality of Life was measured using the validated Linear Analogue Self-Assessment (LASA) scale.
This measure is a 6-item, 11-point likert scale, validated scoring system that measure of quality of life (QOL), in which QOL is conceptualized as a multidimensional construct with five domains (physical, functional, emotional, spiritual, and social).
In this measure, each domain can score 0 as the worst possible and 10 being the best possible.
The total score for QoL could range from 0 to 60 with higher score indicating greater QoL.
Change from Day 90 to Baseline for the LASA score
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ivana T Croghan, PhD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2021
Primary Completion (Actual)
August 1, 2024
Study Completion (Actual)
September 1, 2024
Study Registration Dates
First Submitted
February 3, 2021
First Submitted That Met QC Criteria
February 5, 2021
First Posted (Actual)
February 8, 2021
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 4, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-007207
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
Clinical Trials on Muse S™ Headband system
-
Mayo ClinicCompletedCOVID-19 | Post Acute Sequelae of SARS-CoV-2United States
-
Mayo ClinicCompletedInsomnia | Sleep Disturbance | Women's HealthUnited States
-
Center For Interventional Pain and SpineCeléri Health, Inc.; InteraXonCompletedChronic PainUnited States
-
Newmarket Electrophysiology Research Group IncUnknown
-
Massachusetts General HospitalCompleted
-
Abbott Medical DevicesCompletedSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
University of Campania Luigi VanvitelliDentsply Sirona Implants and ConsumablesCompleted
-
Federal University of São PauloJohnson & JohnsonCompletedStress Urinary IncontinenceBrazil
-
Assiut UniversityNot yet recruitingAirway Complication of AnesthesiaEgypt
-
Dartmouth-Hitchcock Medical CenterCompletedBreast Reconstruction | Breast Hypertrophy | Abdominal ElastosisUnited States